{"version":"1.0","provider_name":"The Ethical Nag","provider_url":"http:\/\/ethicalnag.org","author_name":"Carolyn Thomas","author_url":"https:\/\/ethicalnag.org\/author\/czthomas\/","title":"“Pay for Delay”- how off-patent brand name drugs fight off generics","type":"link","html":"Drug giant Eli Lilly soon faces the loss of patent protection on four out of its top five brand name drugs - accounting for half of annual revenues.","thumbnail_url":"http:\/\/carolynthomas.files.wordpress.com\/2010\/04\/drugs-cymbalta.gif?fit=440%2C330","thumbnail_width":null,"thumbnail_height":null}